Terug
48
Dagbereik
€ 13,55
€ 14,12
52-Weeksbereik
€ 6,68
€ 20,76
Volume
1.228.656
50D / 200D Gem.
€ 16,24
/
€ 14,47
Vorige Slotkoers
€ 13,58
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -35,4 | 0,4 |
| P/B | 9,6 | 2,9 |
| ROE % | -28,2 | 3,8 |
| Net Margin % | -21,5 | 3,9 |
| Rev Growth 5Y % | 15,7 | 10,0 |
| D/E | 1,3 | 0,2 |
Koersdoel Analisten
Hold
€ 21,25
+55.6%
Low: € 21,00
High: € 22,00
Forward WPA
-€ 0,48
Omzet Sch.
280 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,01
-€ 0,01 – -€ 0,01
|
640 M | 2 |
| FY2029 |
€ 0,09
€ 0,08 – € 0,09
|
510 M | 2 |
| FY2028 |
-€ 0,06
-€ 0,29 – € 0,06
|
420 M | 4 |
Belangrijkste Punten
Revenue grew 15,74% annually over 5 years — strong growth
Negative free cash flow of -48,95M
PEG of 0,65 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 39,03%
Capital efficient — spends only 1,07% of revenue on capex
Groei
Revenue Growth (5Y)
15,74%
Revenue (1Y)54,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-28,23%
ROIC-8,58%
Net Margin-21,48%
Op. Margin-20,62%
Veiligheid
Debt / Equity
1,28
Current Ratio3,34
Interest Coverage-4,85
Waardering
P/E Ratio
-35,35
P/B Ratio9,61
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 54,77% | Revenue Growth (3Y) | 27,54% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15,74% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 276,98M | Net Income (TTM) | -59,50M |
| ROE | -28,23% | ROA | -11,60% |
| Gross Margin | 74,24% | Operating Margin | -20,62% |
| Net Margin | -21,48% | Free Cash Flow (TTM) | -48,95M |
| ROIC | -8,58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,28 | Current Ratio | 3,34 |
| Interest Coverage | -4,85 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -35,35 | P/B Ratio | 9,61 |
| P/S Ratio | 7,59 | PEG Ratio | 0,65 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,10B | Enterprise Value | 2,31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 276,98M | 178,96M | 170,28M | 185,31M | 154,34M |
| Net Income | -59,50M | -159,49M | -225,25M | -200,19M | -207,28M |
| EPS (Diluted) | -0,39 | -1,08 | -1,56 | -1,00 | -1,46 |
| Gross Profit | 205,62M | 106,88M | 94,72M | 127,40M | 105,04M |
| Operating Income | -57,12M | -162,55M | -227,04M | -200,19M | -208,97M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 512,74M | 539,38M | 661,13M | 856,62M | 923,34M |
| Total Liabilities | 287,74M | 336,89M | 352,86M | 392,52M | 319,24M |
| Shareholders' Equity | 218,79M | 202,71M | 308,40M | 464,17M | 603,99M |
| Total Debt | 280,58M | 89,39M | 98,77M | 108,00M | 111,74M |
| Cash & Equivalents | 70,50M | 47,92M | 65,06M | 90,03M | 139,07M |
| Current Assets | 300,19M | 283,75M | 410,19M | 562,15M | 402,75M |
| Current Liabilities | 89,92M | 98,05M | 88,02M | 109,79M | 113,81M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#63 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026